检索

搜索所有类别
高级过滤器
关键词	删除

搜索类别
作者
标题
摘要
全文
搜扫PDF文档
补充文件
日期
从
到
索引项目
学科
类型 (method/approach)
覆盖
所有索引词字段

期

标题

作者

卷 27, 编号 2 (2025)

Novel therapies for the metastatic HER2-positive breast cancer with metastases in the central nervous system: a clinical case

Radyukova I., Rats N.

(Rus)

卷 15, 编号 2 (2013)

Breast cancer: from guidelines to personalized oncology

PierFranco C., Valentina G.

()

()

()

()

()

()

()

卷 27, 编号 1 (2025)

Evolution of anti-HER2 therapy in advanced HER2+ breast cancer or “why is trastuzumab still a key player?”. A review

Grechukhina K., Sukhova M., Kolyago E., Filonenko D., Zhukova L.

(Rus)

卷 17, 编号 2 (2015)

Brain metastases in her2-positive breast cancer: new opportunities for systemic therapy

Artamonova E., Manziuk L.

()

()

()

()

()

()

()

卷 25, 编号 3 (2023)

Real-world experience with trastuzumab deruxtecan in patients with metastatic HER2-positive breast cancer and HER2-positive gastric cancer: A retrospective study

Evdokimov V., Bloshchinenko A., Abolmasov A., Vilensky A., Laskov M.

(Rus)

卷 16, 编号 4 (2014)

The effect of combinated treatment of a metastatic HER2-positive stomach cancer

Khvastunov R., Nenarokomov A., Tolstopiatov S., Babina K.

()

()

()

()

()

()

()

卷 25, 编号 1 (2023)

Following in the footsteps of SABCS 2022: top 12 advanced breast cancer studies that could change our clinical practice: A review

Kolyadina I.

(Rus)

卷 16, 编号 3 (2014)

HER2-positive disseminated gastric and gastro-oesophageal junction adenocarcinoma: forecast, clinical course, treatment

Besova N.

()

()

()

()

()

()

()

卷 23, 编号 4 (2021)

Features of response to modern neoadjuvant chemotherapy with dual anti-HER2 blockade (trastuzumab and pertuzumab) in the patients with HER2-positive breast cancer stage II–III

Morozov D., Kolyadina I., Poddubnaya I., Ganshina I., Khokhlova S., Kоmetova V., Rodionov V.

(Rus)

卷 16, 编号 3 (2014)

Personalized approach to HER2-positive advanced breast cancertherapy

Stenina M.

()

()

()

()

()

()

()

卷 20, 编号 2 (2018)

Optimal duration of adjuvant trastuzumab therapy in patients with HER2-possitive early breast cancer: whether the problem is resolved?

Zhukova L., Ganshina I., Khatkova E., Tikhomirova T., Kondratyeva O.

(Rus)

卷 16, 编号 2 (2014)

High efficiency of lapatinib in combination with capecitabine in patient with metastatic HER2-positive synchronous breast cancer (case study)

Seryakov A., Ovchinnikova L., Zabelin M., Yakubov T., Sidorov D., Ovchinnikov M.

()

()

()

()

()

()

()

卷 27, 编号 3 (2025)

New approaches in the treatment of aggressive subtypes of endometrial cancer and the prognostic role of HER2 status of the tumor: A systematic review

Saevets V., Kuzmin N., Shamanova A.

(Rus)

卷 19, 编号 1 (2017)

Pharmacoeconomic aspects of biosimilars

Tryakin A., Rudakova A., Fogt S., Vaganov A., Tolkacheva D.

(Rus)

()

()

()

()

()

()

()

卷 27, 编号 3 (2025)

Following in the footsteps of ASCO-2025: TOP studies that will change the treatment strategy of advanced HR+ and HER2+ breast cancer. A review

Kolyadina I., Poddubnaya I.

(Rus)

卷 18, 编号 2 (2016)

Bioequivalence assessment of BCD-022 (trastuzumab, manufactured by JSC BIOCAD, Russia) as compared with Herceptin® (F.Hoffmann-La Roche Ltd., Switzerland), used in combination with paclitaxel in HER2-positive metastatic breast cancer patients: findings of the international, double-blind phase III clinical study

Ignatova E., Burdaeva O., Kopp M., Kotiv B., Udovitsa D., Stroiakovskii D., Alekseev S., Sheveleva L., Khorinko A., Shapovalova I., Moiseenko V., Ivanov R.

(Rus)

()

()

()

()

()

()

()

卷 15, 编号 1 (2013)

Current approach to adjuvant therapy for breast cancer (a review)

Conte P., Guarneri V.

()

()

()

()

()

()

()

卷 17, 编号 4 (2015)

Neoadjuvant systemic therapy of HER2-positive breast cancer

Frolova M.

()

()

()

()

()

()

()

1 - 18 的 18 信息

检索提示:

检索的名词区分大小写
常用字词将被忽略
默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
使用引号检索一个完整的词组; 例如： "open access publishing"
使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

用户名
密码
记住我

忘记您的密码?	注册

用户名
密码
记住我

忘记您的密码?	注册

检索

高级过滤器

搜索类别

日期

索引项目

检索提示: